Deutsche Bank analysts provided their outlook on Colgate-Palmolive Company (NYSE:CL) ahead of the upcoming Q3 results, lowering their price target on the company’s shares to $85 from $87.
The analysts expect solid Q3 results, with lingering gross margin pressure (a product of still-high underlying inflation and building transaction FX headwinds) offset by strong organic growth (7-8%) balanced across geographic segments and Hill’s.
For fiscal 2022, the analysts see a limited change to full-year EPS despite higher FX headwinds, as strong organic growth momentum, building productivity, and sequentially easing input and logistics cost pressures in Q4 should serve as offsets (with the company’s elective rate of reinvestment a potential wild card).
